Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Product sales, net	$ 8,973,982	$ 8,629,928
Cost of products sold	2,566,405	2,195,340
Gross profit	6,407,577	6,434,588
Selling, general and administrative expenses	11,576,530	12,295,330
Research and development expenses	449,469	858,767
Depreciation and amortization expense	78,195	37,448
Total operating expenses	12,104,194	13,191,545
Loss from operations	(5,696,617)	(6,756,957)
Interest (expense) income, net	(25,599)	60,265
Gain on sale of net operating losses		1,983,095
Loss before provision for income taxes	(5,722,216)	(4,713,597)
Provision for income taxes
Net loss	$ (5,722,216)	$ (4,713,597)
Net loss per share applicable to common stockholders - basic	$ (0.07)	$ (0.06)
Net loss per share applicable to common stockholders - diluted	$ (0.07)	$ (0.06)
Weighted average shares outstanding and to be issued - basic	82,064,109	79,791,188
Weighted average shares outstanding and to be issued - diluted	82,064,109	79,791,188